Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
The Journal of General Virology|November 15, 2008
Functional importance of dengue virus maturation: infectious properties of immature virionsIzabela A Zybert, Heidi van der Ende-Metselaar, Jan Wilschut, et al.
Vaccine|July 6, 2010
Lipopeptide-adjuvanted respiratory syncytial virus virosomes: A safe and immunogenic non-replicating vaccine formulationToon Stegmann, Tobias Kamphuis, Tjarko Meijerhof, et al.
Influenza and Other Respiratory Viruses|May 21, 2009
Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCsFelix Geeraedts, Laura Bungener, Judith Pool, et al.
Vaccine|March 19, 2013
Efficacy and safety of an intranasal virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice and cotton ratsTobias Kamphuis, Muhammad Shafique, Tjarko Meijerhof, et al.
Vaccine|April 11, 2008
Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protectionLaura Bungener, Felix Geeraedts, Wouter Ter Veer, et al.
Vaccine|January 22, 2011
Preclinical evaluation of the saponin derivative GPI-0100 as an immunostimulating and dose-sparing adjuvant for pandemic influenza vaccinesHeng Liu, Laura Bungener, Wouter ter Veer, et al.
Advanced Drug Delivery Reviews|November 25, 2004
Virosomes for antigen and DNA deliveryToos Daemen, Arjan de Mare, Laura Bungener, et al.
Biochimica Et Biophysica Acta|April 25, 2006
Use of a dialyzable short-chain phospholipid for efficient solubilization and reconstitution of influenza virus envelopesJørgen de Jonge, Pieter Schoen, Wouter ter Veer, et al.
Idcases|November 18, 2017
Severity of acute Zika virus infection: A prospective emergency room surveillance study during the 2015-2016 outbreak in SurinamePieter Vroon, Jimmy Roosblad, Fauzia Poese, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|February 2, 2006
Recombinant alphaviruses as vectors for anti-tumour and anti-microbial immunotherapyAnnelies Riezebos-Brilman, Arjan de Mare, Laura Bungener, et al.
Pageof 9